TP53 and cancer: Consistent with the expression pattern observed in human (Fig. 1f), β-galactosidase staining in murine pancreata showed an increase in premalignant lesions driven by KrasG12D, but no staining was detected in overt cancer upon concomitant loss of Trp53 (Fig. 1h and IHC in Supplementary Fig. 1m).